recombinant subunit herpes zoster vaccine

BIOLOGICAL2 trials

Sponsors

University Health Network, Toronto, Tuen Mun Hospital

Conditions

Herpes ZosterVaricella Zoster Vaccine

Phase 3

Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients

CompletedNCT03685682

University Health Network, TorontoVaricella Zoster Vaccine

Start: 2018-05-25End: 2019-09-05Updated: 2020-08-05

Phase 4

Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT

Not yet recruitingNCT04748939

Tuen Mun HospitalHerpes Zoster

Start: 2025-01-31End: 2026-07-31Target: 140Updated: 2024-08-06